Ira Duarte Heron Therapeutics, Inc. (HRTX) insider trading activity

Ira Duarte is EVP, Chief Financial Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 179,786 shares of HRTX, which is worth approximately $197,764. The most recent transaction as insider was on Oct 31, 2025, when has been sold 11,694 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 180K

9.48% 3M change

66.47% 12M change

Total Value Held $197,764

Ira Duarte Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 31 2025	BUY Exercise of conversion of derivative security	-	11,694 Added 6.11%	179,786 Common Stock
Oct 19 2025	BUY Exercise of conversion of derivative security	-	3,874 Added 2.25%	168,092 Common Stock
Jul 31 2025	BUY Exercise of conversion of derivative security	-	11,695 Added 6.65%	164,218 Common Stock
Jul 19 2025	BUY Exercise of conversion of derivative security	-	3,874 Added 2.48%	152,523 Common Stock
Jun 16 2025	BUY Exercise of conversion of derivative security	-	12,500 Added 7.76%	148,649 Common Stock
Apr 30 2025	BUY Exercise of conversion of derivative security	-	11,694 Added 7.91%	136,149 Common Stock
Apr 19 2025	BUY Exercise of conversion of derivative security	-	3,875 Added 3.02%	124,455 Common Stock

Jan 19 2025	BUY Exercise of conversion of derivative security	-	3,874 Added 3.11%	120,580 Common Stock
Oct 19 2024	BUY Exercise of conversion of derivative security	-	3,874 Added 3.46%	108,001 Common Stock
Jul 19 2024	BUY Exercise of conversion of derivative security	-	3,875 Added 3.59%	104,127 Common Stock
Jun 16 2024	BUY Exercise of conversion of derivative security	-	12,500 Added 11.09%	100,252 Common Stock
Apr 19 2024	SELL Payment of exercise price or tax liability	$2,962 $2.64 p/Share	1,122 Reduced 1.26%	87,752 Common Stock
Apr 19 2024	BUY Exercise of conversion of derivative security	-	3,874 Added 4.18%	88,874 Common Stock
Nov 16 2023	BUY Open market or private purchase	$75,650 $0.89 p/Share	85,000 Added 50.0%	85,000 Common Stock

Also insider at

TRSSF

TerrAscend Corp. Healthcare

Ira Duarte

EVP, Chief Financial Officer

Mississauga, A6

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to HERON THERAPEUTICS, INC.

Track Activities on HRTX

Account